IBB — iShares Biotechnology ETF
iShares Biotechnology ETF (ticker: IBB) is a equity ETF issued by BlackRock, Inc. tracking ICE Biotechnology Index. It was launched on 2001-02-05.
About IBB
The iShares Biotechnology ETF (IBB) is an equity fund that aims to track the ICE Biotechnology Index. It invests in U.S. biotechnology companies.
This fund may be considered by investors seeking exposure to the biotechnology sector of the U.S. equity market.
- Tracks the ICE Biotechnology Index.
- Invests in 259 biotechnology companies.
- Expense ratio of 0.44%.
- AUM of $7.91B.
- Top holdings include Gilead Sciences Inc, Amgen Inc, and Vertex Pharmaceuticals Inc.
Returns (Total Return)
| Period | Return |
|---|---|
| 1 Day | 1.97% |
| 1 Week | -1.40% |
| 1 Month | 0.14% |
| 3 Months | -1.53% |
| 6 Months | -2.75% |
| YTD | -0.75% |
| 1 Year | 34.26% |
| 3 Years | 30.71% |
| 5 Years | 12.29% |
| 10 Years | — |
| Since Inception | — |
Top Holdings
| # | Security | Symbol | Weight |
|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 10.49% |
| 2 | GILEAD SCIENCES INC | GILD | 10.49% |
| 3 | GILEAD SCIENCES INC | GILD | 10.49% |
| 4 | GILEAD SCIENCES INC | GILD | 10.49% |
| 5 | GILEAD SCIENCES INC | GILD | 10.49% |
| 6 | GILEAD SCIENCES INC | GILD | 9.75% |
| 7 | GILEAD SCIENCES INC | GILD | 9.75% |
| 8 | GILEAD SCIENCES INC | GILD | 9.75% |
| 9 | GILEAD SCIENCES INC | GILD | 9.66% |
| 10 | GILEAD SCIENCES INC | GILD | 9.66% |
Fund Profile
| Issuer | BlackRock, Inc. |
|---|---|
| Brand | iShares |
| Asset Class | equity |
| Strategy | Vanilla |
| Structure | ETF |
| Category | Health & Biotech Equities |
| Segment | Equity: U.S. Biotechnology |
| Sector | Biotechnology |
| Region | North America |
| Index Tracked | ICE Biotechnology Index |
| Inception Date | 2001-02-05 |
| Tax on Distributions | Qualified dividends |
Quick Facts
| Ticker | IBB |
|---|---|
| Full Name | iShares Biotechnology ETF |
| Issuer | BlackRock, Inc. |
| Asset Class | equity |
| Expense Ratio | 0.00% |
| AUM | $7.53B |
| Inception | 2001-02-05 |
| Index Tracked | ICE Biotechnology Index |
Frequently Asked Questions
What does IBB track?
IBB (iShares Biotechnology ETF) tracks ICE Biotechnology Index, a equity benchmark.
What is the expense ratio of IBB?
IBB has an expense ratio of 0.00% per year.
What is the AUM of IBB?
IBB has approximately $7.53B in assets under management.
Does IBB pay a dividend?
IBB distributes income according to its prospectus (Qualified dividends tax treatment). Check the dividend history tab for ex-dividend dates and yield.
Who issues IBB?
IBB is issued by BlackRock, Inc. under the iShares brand, launched on 2001-02-05.
Open the interactive IBB dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.